dr. Nina Dwi Putri, Sp.A(K), MSc(TropPaed)
Head of Clinical Research ImplementationPediatric Infectious Disease Consultant | MSc Tropical Medicine (UK) | Researcher in Dengue, CMV & Zika | OPAT Pioneer in Indonesia
Personal Information
- Email Address : ninadwip@gmail.com, nina.dwi@ikafkui.net
- Location : Jakarta, Indonesia
- Nationality : Indonesian
- Languages : Indonesian (Native), English (Advanced)
- Speciality : Pediatric Infectious Disease & Tropical Pediatrics
Education
2022 - Present
Advanced research in pediatric infectious diseases with focus on antimicrobial resistance and vaccine development
2018 - 2019
Thomas Mark Award recipient
2015 - 2017
Graduated with cum laude
2007 - 2012
Second best score nationally
2000 - 2006
Experience
Field Coordinator of Pediatric Infectious Disease Clinical Research Unit
2020 - Present
Leading pediatric infectious disease research initiatives, coordinating multi-center clinical trials and epidemiological studies, managing research projects funded by international organizations.
Head of Antimicrobial Stewardship
2021 - Present
Implementing antimicrobial stewardship programs, optimizing antibiotic use in pediatric patients, training healthcare professionals on rational antimicrobial use.
Lecturer
31 March 2015 - Present
Teaching medical students and residents, supervising clinical research projects, developing curriculum for pediatric infectious disease training.
Medical Staff
3 March 2014 - Present
Providing clinical care for pediatric patients with infectious diseases, conducting outbreak investigations and infection control, participating in antimicrobial stewardship and vaccine programs.
Publications
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
DOI: 10.3390/vaccines12040344
Emerging progressive atypical acute kidney injury in young children linked to ethylene glycol and diethylene glycol intoxication
DOI: 10.1007/s00467-023-06155-8
Pediatric sepsis profile in a tertiary-care hospital in Indonesia: a 4 year retrospective study
DOI: 10.1093/tropej/fmad029
Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia
DOI: 10.1016/S1473-3099(22)00800-2
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults
DOI: 10.1056/NEJMoa2202261
Clinical Features of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in Indonesia
DOI: 10.1093/tropej/fmac025
Meet the Team
This sub-unit carries out the operational aspects of clinical research in accordance with study protocols, including subject recruitment, implementation of interventions, data collection, and monitoring compliance with ethical and regulatory standards.
Anastasia is a study nurse at the Clinical Research Implementation Sub Unit, with experience in clinical trial support and patient care. Her responsibilities include subject screening, clinical monitoring, and the administration of investigational treatments in accordance with study protocols. With formal training in Good Clinical Practice and Clinical Research During Outbreaks, she contributes to the effective conduct of clinical trials, patient safety, and continuous healthcare quality improvement.
Marlis is an administrative officer in clinical trials with a Master's degree in Public Administration. She focused on ensuring accurate documentation and efficient study coordination as well as managing trial documents and schedules to support seamless execution. She contributes to compliance, streamlined workflows, and the overall success of clinical research activities.
Jihan is a pharmacist with extensive experience in managing Investigational Products (IP) and facilitating clinical trial site activation. She is responsible for ensuring proper handling, storage, documentation, and accountability of IP in compliance with regulatory standards and Good Clinical Practice. In addition, she plays a key role as a facilitator in site activation processes, supporting sponsors and CROs in conducting feasibility assessments, coordinating regulatory document preparation, and ensuring timely site readiness. She actively collaborates with cross-functional teams to streamline study start-up activities, enabling efficient and compliant clinical trial execution.
Siska is a dedicated and experienced nursing professional with decades of clinical experience in pediatric, maternity, and oncology care settings, complemented by hands-on involvement as a study nurse in clinical trials. She demonstrates strong expertise in Good Clinical Practice, patient safety, and clinical data management, ensuring strict adherence to study protocols and regulatory requirements. She is highly committed to supporting excellence in clinical research and improving healthcare outcomes.
Dedi is an experienced nursing professional with a strong background in cardiovascular care. As a study nurse, he has actively supported the implementation of clinical trials in compliance with Good Clinical Practice, ensuring protocol adherence, participant safety, and data quality. Passionate about advancing medical science, he is dedicated to contributing to high-quality research that drives innovation and improves patient outcomes.